Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 311.19M | 257.99M | 259.14M | 204.34M | 151.83M | 536.61M |
Gross Profit | 16.49M | 30.23M | 46.31M | 39.84M | 19.51M | 54.23M |
EBITDA | -13.42M | 3.04M | 25.32M | 9.33M | 3.54M | 29.61M |
Net Income | -5.75M | 8.28M | 12.66M | 4.26M | 21.12M | 12.76M |
Balance Sheet | ||||||
Total Assets | 382.83M | 352.85M | 341.27M | 272.35M | 276.54M | 218.97M |
Cash, Cash Equivalents and Short-Term Investments | 30.05M | 32.07M | 66.03M | 56.56M | 91.30M | 54.87M |
Total Debt | 105.55M | 73.82M | 65.39M | 23.07M | 31.91M | 1.45M |
Total Liabilities | 226.95M | 183.17M | 179.87M | 123.61M | 132.07M | 95.62M |
Stockholders Equity | 155.88M | 169.68M | 161.40M | 148.74M | 144.47M | 123.35M |
Cash Flow | ||||||
Free Cash Flow | -30.77M | -16.67M | -25.84M | -7.36M | 81.41M | -93.90M |
Operating Cash Flow | -19.37M | -5.27M | -20.50M | -2.90M | 81.62M | -91.44M |
Investing Cash Flow | -15.46M | -32.36M | -8.85M | -13.05M | -73.20M | -92.24M |
Financing Cash Flow | 34.58M | 3.68M | 38.82M | -18.80M | 28.01M | -35.46M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | HK$258.89M | 10.07 | 4.67% | 3.39% | 7.39% | 142.61% | |
72 Outperform | HK$8.45B | 20.77 | 6.48% | 11.66% | -22.77% | -53.94% | |
71 Outperform | ¥255.75B | 13.62 | 8.48% | 4.48% | 6.34% | 13.16% | |
54 Neutral | $13.44B | ― | -4.63% | 2.79% | -4.61% | -1035.60% | |
52 Neutral | HK$61.60M | ― | -35.67% | ― | 10.44% | -155.38% | |
43 Neutral | HK$489.89M | ― | -20.68% | ― | -14.44% | -14025.00% |